ThinkCyte: Valuation, Funding & Investors
ThinkCyte is a biotechnology company that leverages artificial intelligence for advanced cell analysis, focusing on applications in research and diagnostics. The company aims to revolutionize the field by integrating cutting-edge AI technology to enhance the precision and efficiency of cell analysis processes.
Leadership & Board
- Current Number of Employees
- 47
- Current LinkedIn Followers
- 3,253
Latest Estimated Valuation
- Total Amount Raised
- $32M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $32M
- Latest Funding Round
- Series C
Company Momentum Positive
ThinkCyte LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
ThinkCyte had 47 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
ThinkCyte had 3,253 followers as of October 26, 2026. The number of followers increased by 6 (0.18%) week-over-week.
Main Enterprise Clients
A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 14, 2025 | Series C | $32.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Japan Green Investment Corp. for Carbon Neutrality | Series C |
| KIRIN-GB Fund I L.P. | Series C |
| SMBC Venture Capital No. 7 Investment Limited Partnership | Series C |
Similar Companies
A snapshot of private companies similar to ThinkCyte, helping you discover and navigate related company profiles.
Related News and Analysis
